ClinicalTrials.Veeva

Menu

Identification of Anaphylactogenic Antibodies in Peanut Allergy

University of Zurich (UZH) logo

University of Zurich (UZH)

Status

Invitation-only

Conditions

Peanut Allergy

Treatments

Other: Observational study

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

This project intends the analysis and profiling of specific antibodies against major peanut allergens in peanut allergic individuals and molecular cloning of human antibodies against major peanut allergens.

Full description

  • Characterization of patient samples reactivity (sera obtained from blood) against major peanut allergens.
  • Isolation of antibody-producing B cells.
  • Molecular cloning of peanut-specific antibodies from antibody gene sequences obtained from B cells.
  • Biophysical and functional characterization of isolated antibodies

Enrollment

100 estimated patients

Sex

All

Ages

3+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Participants have a described clinical history of peanut allergy and/or are sensitized to peanut allergens (as evidenced by positive skin prick test and allergen-specific IgE testing)
  • Male and female subjects older than 3 years
  • Written informed consent

Exclusion criteria

  • age below three years
  • patients suffering from any disease where blood withdrawals might impact the patients' health status such as known anemia.

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems